Fosun’s $692 Million Bid to Take Henlius Biotech Private: A Surge in Hong Kong Take-Private Deals

Pieter Gunst01 mins

In recent developments, law firms Reed Smith and Freshfields have been engaged in advising on Fosun’s $692 million take-private offer for the Hong Kong-listed Henlius Biotech. According to Dealogic data, Hong Kong-listed companies have been part of take-private deals worth $4 billion as of March, a notable increase compared to $1.2 billion for all of 2023. For more detailed information, you can visit the original article here.